Willey Michael C, Hebden Joan N, Herwaldt Loreen A, Gaski Greg E, Kheiri Sara, O'Hara Lyndsay M, O'Hara Nathan N, Sprague Sheila, Bzovsky Sofia, Gage Mark J, Slobogean Gerard P
Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.
J Bone Joint Surg Am. 2025 Jun 18;107(Suppl 1):36-42. doi: 10.2106/JBJS.24.01224.
A preoperative chlorhexidine gluconate (CHG) bath is used to reduce the risk of surgical site infection (SSI) in elective surgery, but its efficacy in the trauma setting is unknown. We compared the incidence of SSI between patients who did versus did not receive a CHG bath before operative fixation of extremity and/or pelvic fractures.
We conducted a secondary analysis of the PREP-IT cluster-randomized crossover trials that enrolled patients undergoing operative treatment for open or closed extremity or pelvic fractures. Preoperative CHG bathing (yes or no) was recorded for each patient per study protocol. The association between CHG bathing and SSI within 90 days after definitive fracture surgery was assessed. We performed multivariable regression to adjust for prognostic variables. We also conducted a separate instrumental variable analysis to compare SSI rates between study sites that used CHG bathing for >90% of participants and those that used CHG bathing for <1% of participants.
Of the 10,103 participants (mean age, 51 ± 20 years; 47% female; 77% White; 17% Black; 4% Asian; 7% Hispanic) included in the analysis, 2,674 (26%) had a documented preoperative CHG bath and 7,429 (74%) did not. CHG bathing was not associated with a significant reduction in the odds of 90-day SSI in the multivariable (odds ratio [OR], 1.07; 95% confidence interval [CI], 0.86 to 1.32; p = 0.56) or instrumental variable (OR, 0.88; 95% CI, 0.62 to 1.25; p = 0.48) analyses.
Among adult patients who underwent extremity or pelvic fracture surgery, preoperative CHG bathing was not associated with a significant reduction in SSI.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
术前使用葡萄糖酸氯己定(CHG)沐浴可降低择期手术中手术部位感染(SSI)的风险,但其在创伤环境中的疗效尚不清楚。我们比较了在进行四肢和/或骨盆骨折手术固定之前接受与未接受CHG沐浴的患者之间SSI的发生率。
我们对PREP-IT整群随机交叉试验进行了二次分析,该试验纳入了接受开放性或闭合性四肢或骨盆骨折手术治疗的患者。根据研究方案记录每位患者术前是否进行CHG沐浴。评估了CHG沐浴与确定性骨折手术后90天内SSI之间的关联。我们进行了多变量回归以调整预后变量。我们还进行了一项单独的工具变量分析,以比较CHG沐浴使用率>90%的研究地点与CHG沐浴使用率<1%的研究地点之间的SSI发生率。
纳入分析的10103名参与者(平均年龄51±20岁;47%为女性;77%为白人;17%为黑人;4%为亚洲人;7%为西班牙裔)中,2674名(26%)有术前CHG沐浴的记录,7429名(74%)没有。在多变量分析(比值比[OR]为1.07;95%置信区间[CI]为0.86至1.32;p=0.56)或工具变量分析(OR为0.88;95%CI为0.62至1.25;p=0.48)中,CHG沐浴与90天SSI的几率显著降低无关。
在接受四肢或骨盆骨折手术的成年患者中,术前CHG沐浴与SSI的显著降低无关。
治疗性III级。有关证据水平完整描述,请参阅作者指南。